D-0449-2026 Class II Ongoing

Recalled by Cipla USA, Inc. — Warren, NJ

Recall Details

Product Type
Drugs
Report Date
April 22, 2026
Initiation Date
March 16, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
113,336 bottles

Product Description

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

Reason for Recall

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Distribution Pattern

Nationwide in the USA

Code Information

Lot, expiry: Lot 4PB0526, 4PB0527, 4PB0528, exp September-2026; Lot 5PB0173, exp January-2027